Research letter
Fixed drug eruption due to norfloxacin and cross-reactivity with other quinolones
Read
7743
Timeswas read the article
1412
Total PDF
6331
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 47 | 1 | 48 |
| 2025 11 | 201 | 21 | 222 |
| 2025 10 | 158 | 13 | 171 |
| 2025 9 | 151 | 11 | 162 |
| 2025 8 | 144 | 14 | 158 |
| 2025 7 | 169 | 6 | 175 |
| 2025 6 | 126 | 3 | 129 |
| 2025 5 | 168 | 3 | 171 |
| 2025 4 | 137 | 6 | 143 |
| 2025 3 | 149 | 4 | 153 |
| 2025 2 | 92 | 8 | 100 |
| 2025 1 | 122 | 9 | 131 |
| 2024 12 | 149 | 8 | 157 |
| 2024 11 | 127 | 9 | 136 |
| 2024 10 | 120 | 10 | 130 |
| 2024 9 | 102 | 6 | 108 |
| 2024 8 | 95 | 14 | 109 |
| 2024 7 | 114 | 14 | 128 |
| 2024 6 | 61 | 6 | 67 |
| 2024 5 | 66 | 8 | 74 |
| 2024 4 | 76 | 9 | 85 |
| 2024 3 | 83 | 11 | 94 |
| 2024 2 | 103 | 8 | 111 |
| 2024 1 | 116 | 20 | 136 |
| 2023 12 | 101 | 9 | 110 |
| 2023 11 | 102 | 16 | 118 |
| 2023 10 | 125 | 4 | 129 |
| 2023 9 | 95 | 10 | 105 |
| 2023 8 | 80 | 8 | 88 |
| 2023 7 | 105 | 7 | 112 |
| 2023 6 | 74 | 6 | 80 |
| 2023 5 | 90 | 10 | 100 |
| 2023 4 | 114 | 3 | 117 |
| 2023 3 | 91 | 10 | 101 |
| 2023 2 | 56 | 5 | 61 |
| 2023 1 | 66 | 9 | 75 |
| 2022 12 | 41 | 8 | 49 |
| 2022 11 | 28 | 7 | 35 |
| 2022 10 | 27 | 12 | 39 |
| 2022 9 | 46 | 9 | 55 |
| 2022 8 | 34 | 12 | 46 |
| 2022 7 | 27 | 17 | 44 |
| 2022 6 | 31 | 13 | 44 |
| 2022 5 | 27 | 7 | 34 |
| 2022 4 | 27 | 18 | 45 |
| 2022 3 | 32 | 13 | 45 |
| 2022 2 | 28 | 8 | 36 |
| 2022 1 | 39 | 32 | 71 |
| 2021 12 | 13 | 24 | 37 |
| 2021 11 | 18 | 14 | 32 |
| 2021 10 | 14 | 14 | 28 |
| 2021 9 | 19 | 24 | 43 |
| 2021 8 | 22 | 15 | 37 |
| 2021 7 | 10 | 18 | 28 |
| 2021 6 | 32 | 16 | 48 |
| 2021 5 | 15 | 9 | 24 |
| 2021 4 | 26 | 8 | 34 |
| 2021 3 | 8 | 38 | 46 |
| 2021 2 | 12 | 11 | 23 |
| 2021 1 | 8 | 15 | 23 |
| 2020 12 | 1 | 1 | 2 |
| 2020 11 | 0 | 2 | 2 |
| 2020 10 | 0 | 1 | 1 |
| 2020 9 | 0 | 1 | 1 |
| 2020 7 | 0 | 2 | 2 |
| 2020 6 | 0 | 1 | 1 |
| 2020 5 | 0 | 4 | 4 |
| 2020 4 | 0 | 2 | 2 |
| 2020 3 | 0 | 2 | 2 |
| 2020 2 | 0 | 2 | 2 |
| 2020 1 | 0 | 3 | 3 |
| 2019 12 | 0 | 1 | 1 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 0 | 3 | 3 |
| 2019 9 | 0 | 2 | 2 |
| 2019 8 | 0 | 2 | 2 |
| 2019 7 | 0 | 3 | 3 |
| 2019 6 | 0 | 12 | 12 |
| 2019 5 | 0 | 48 | 48 |
| 2019 4 | 0 | 13 | 13 |
| 2019 3 | 0 | 1 | 1 |
| 2019 1 | 0 | 4 | 4 |
| 2018 3 | 0 | 1 | 1 |
| 2018 2 | 8 | 6 | 14 |
| 2018 1 | 20 | 6 | 26 |
| 2017 12 | 12 | 3 | 15 |
| 2017 11 | 10 | 8 | 18 |
| 2017 10 | 22 | 20 | 42 |
| 2017 9 | 13 | 4 | 17 |
| 2017 8 | 15 | 10 | 25 |
| 2017 7 | 21 | 9 | 30 |
| 2017 6 | 22 | 25 | 47 |
| 2017 5 | 26 | 23 | 49 |
| 2017 4 | 23 | 8 | 31 |
| 2017 3 | 18 | 26 | 44 |
| 2017 2 | 27 | 11 | 38 |
| 2017 1 | 13 | 7 | 20 |
| 2016 12 | 21 | 11 | 32 |
| 2016 11 | 26 | 12 | 38 |
| 2016 10 | 47 | 6 | 53 |
| 2016 9 | 42 | 15 | 57 |
| 2016 8 | 31 | 2 | 33 |
| 2016 7 | 22 | 6 | 28 |
| 2016 6 | 37 | 19 | 56 |
| 2016 5 | 27 | 18 | 45 |
| 2016 4 | 30 | 27 | 57 |
| 2016 3 | 24 | 10 | 34 |
| 2016 2 | 23 | 19 | 42 |
| 2016 1 | 21 | 14 | 35 |
| 2015 12 | 25 | 13 | 38 |
| 2015 11 | 20 | 16 | 36 |
| 2015 10 | 40 | 15 | 55 |
| 2015 9 | 26 | 15 | 41 |
| 2015 8 | 42 | 5 | 47 |
| 2015 7 | 42 | 8 | 50 |
| 2015 6 | 16 | 19 | 35 |
| 2015 5 | 12 | 3 | 15 |
| 2015 4 | 8 | 4 | 12 |
| 2015 3 | 9 | 3 | 12 |
| 2015 2 | 6 | 1 | 7 |
| 2015 1 | 19 | 4 | 23 |
| 2014 12 | 34 | 9 | 43 |
| 2014 11 | 13 | 3 | 16 |
| 2014 10 | 16 | 5 | 21 |
| 2014 9 | 29 | 3 | 32 |
| 2014 8 | 16 | 6 | 22 |
| 2014 7 | 7 | 0 | 7 |
| 2014 6 | 9 | 2 | 11 |
| 2014 5 | 10 | 2 | 12 |
| 2014 4 | 11 | 4 | 15 |
| 2014 3 | 63 | 13 | 76 |
| 2014 2 | 55 | 15 | 70 |
| 2014 1 | 49 | 16 | 65 |
| 2013 12 | 44 | 17 | 61 |
| 2013 11 | 34 | 6 | 40 |
| 2013 10 | 37 | 10 | 47 |
| 2013 9 | 39 | 13 | 52 |
| 2013 8 | 36 | 14 | 50 |
| 2013 7 | 47 | 15 | 62 |
| 2013 6 | 45 | 7 | 52 |
| 2013 5 | 51 | 7 | 58 |
| 2013 4 | 40 | 9 | 49 |
| 2013 3 | 29 | 7 | 36 |
| 2013 2 | 5 | 5 | 10 |
| 2013 1 | 186 | 0 | 186 |
Show all
